CliffBio
small molecule

ESZOPICLONE

ESZOPICLONE

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameESZOPICLONE
Active ingredientESZOPICLONE
Strength1MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalSeptember 2011
Marketing statusDISCN

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.